4 results on '"Rodella, S."'
Search Results
2. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
- Author
-
Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, and Arcaro G
- Subjects
- Aged, Diabetes Mellitus, Type 2 drug therapy, Female, Humans, Hypoglycemic Agents therapeutic use, Male, Middle Aged, Prevalence, Risk Factors, Smoking epidemiology, Cardiovascular Diseases epidemiology, Diabetes Mellitus, Type 2 complications, Diabetic Angiopathies epidemiology, Fatty Liver epidemiology
- Abstract
Objective: To determine the prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetic population and to compare the prevalence of cardiovascular disease (CVD) and its risk factors between people with and without NAFLD., Research Design and Methods: The entire sample of type 2 diabetic outpatients (n = 2,839) who regularly attended our clinic was screened. Main outcome measures were NAFLD (by patient history and liver ultrasound) and manifest CVD (by patient history, review of patient records, electrocardiogram, and echo-Doppler scanning of carotid and lower limb arteries)., Results: The unadjusted prevalence of NAFLD was 69.5% among participants, and NAFLD was the most common cause (81.5%) of hepatic steatosis on ultrasound examination. The prevalence of NAFLD increased with age (65.4% among participants aged 40-59 years and 74.6% among those aged > or = 60 years; P < 0.001) and the age-adjusted prevalence of NAFLD was 71.1% in men and 68% in women. NAFLD patients had remarkably (P < 0.001) higher age and sex-adjusted prevalences of coronary (26.6 vs. 18.3%), cerebrovascular (20.0 vs. 13.3%), and peripheral (15.4 vs. 10.0%) vascular disease than their counterparts without NAFLD. In logistic regression analysis, NAFLD was associated with prevalent CVD independent of classical risk factors, glycemic control, medications, and metabolic syndrome features., Conclusions: NAFLD is extremely common in people with type 2 diabetes and is associated with a higher prevalence of CVD. Follow-up studies are needed to determine whether NAFLD predicts the development and progression of CVD.
- Published
- 2007
- Full Text
- View/download PDF
3. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
- Author
-
Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, Cigolini M, Falezza G, and Arcaro G
- Subjects
- Adult, Blood Glucose metabolism, Body Mass Index, Body Weight, Carotid Artery Diseases blood, Carotid Artery Diseases complications, Fatty Liver blood, Fatty Liver complications, Female, Humans, Male, Middle Aged, Triglycerides blood, Carotid Arteries pathology, Carotid Artery Diseases pathology, Fatty Liver pathology, Liver pathology
- Abstract
Objective: Nonalcoholic fatty liver disease (NAFLD) is closely associated with several metabolic syndrome features. We assessed whether NAFLD is associated with carotid artery intima-media thickness (IMT) as a marker of subclinical atherosclerosis and whether such an association is independent of classical risk factors, insulin resistance, and metabolic syndrome features., Research Design and Methods: We compared carotid IMT, as assessed by ultrasonography, in 85 consecutive patients with biopsy-proven NAFLD and 160 age-, sex-, and BMI-matched healthy control subjects., Results: NAFLD patients had a markedly greater carotid IMT (1.14 +/- 0.20 vs. 0.82 +/- 0.12 mm; P < 0.001) than control subjects. The metabolic syndrome (according to Adult Treatment Panel III criteria) and its individual components were more frequent in those with NAFLD (P < 0.001). The marked differences in carotid IMT observed between the groups were only slightly weakened after adjustment for age, sex, BMI, smoking history, LDL cholesterol, insulin resistance (by homeostasis model assessment), and metabolic syndrome components. Notably, carotid IMT was strongly associated with degree of hepatic steatosis, necroinflammation, and fibrosis among NAFLD patients (P < 0.001 for all). Similarly, by logistic regression analysis, the severity of histological features of NAFLD independently predicted carotid IMT (P < 0.001) after adjustment for all potential confounders., Conclusions: These results suggest that the severity of liver histopathology among NAFLD patients is strongly associated with early carotid atherosclerosis, independent of classical risk factors, insulin resistance, and the presence of metabolic syndrome.
- Published
- 2006
- Full Text
- View/download PDF
4. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.
- Author
-
Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, and Falezza G
- Subjects
- Aged, Case-Control Studies, Diabetes Mellitus, Type 2 drug therapy, Female, Follow-Up Studies, Humans, Hypoglycemic Agents therapeutic use, Male, Middle Aged, Models, Biological, Regression Analysis, Risk Factors, Smoking physiopathology, Cardiovascular Diseases epidemiology, Diabetes Mellitus, Type 2 physiopathology, Diabetic Angiopathies epidemiology, Fatty Liver complications
- Abstract
Nonalcoholic fatty liver disease (NAFLD) is closely correlated to several metabolic syndrome features. We assessed prospectively whether NAFLD predicts future cardiovascular disease (CVD) events among type 2 diabetic individuals, independent of metabolic syndrome features and other classical risk factors. We carried out a prospective nested case-control study in 2,103 type 2 diabetic patients who were free of diagnosed CVD at baseline. During 5 years of follow-up, 248 participants (case subjects) subsequently developed nonfatal coronary heart disease (myocardial infarction and coronary revascularization procedures), ischemic stroke, or cardiovascular death. Using risk-set sampling, 496 patients (control subjects) among those who remained free of diagnosed CVD during follow-up were randomly selected in a 2:1 ratio, matched for age and sex to the case subjects. After adjustment for age, sex, smoking history, diabetes duration, HbA1c, LDL cholesterol, liver enzymes, and use of medications, the presence of NAFLD was significantly associated with an increased CVD risk (odds ratio 1.84, 95% CI 1.4-2.1, P < 0.001). Additional adjustment for the metabolic syndrome (as defined by National Cholesterol Education Program Adult Treatment Panel III criteria) appreciably attenuated, but did not abolish, this association (1.53, 1.1-1.7, P = 0.02). In conclusion, NAFLD is significantly associated with a moderately increased CVD risk among type 2 diabetic individuals. This relationship is independent of classical risk factors and is only partly explained by occurrence of metabolic syndrome.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.